Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

4(80.0%)

Phase 4

1(20.0%)

5Total

Phase 2(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05219604Phase 4Terminated

Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling

Role: lead

NCT06282081Active Not Recruiting

Serum Neurofilament Light in Multiple Sclerosis

Role: lead

NCT02158585Phase 2Completed

Study of Lamotrigine to Treat Ménière's Disease

Role: lead

NCT05420350Phase 2Unknown

Lamotrigine and Bupropion for Meniere's Disease

Role: lead

NCT01813591Phase 2Completed

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Role: lead

NCT02008123Phase 2Withdrawn

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Role: lead

All 6 trials loaded